Barry Douglas — SEC Form 4 filings

SEC reporting owner CIK 1890662. 4 Form 4 filings on record with FilingPulse; latest filed 2025-02-06.

Transaction summary — filings shown

Covers all 4 filings on record, filed 2024-02-05 to 2025-02-06. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Tango Therapeutics, Inc. (TNGX)General Counsel44 legs · 8,106 sh · $51,3204

Form 4 filings — Barry Douglas

FiledFormIssuerReported transactionsSource
2025-02-064Tango Therapeutics, Inc. (TNGX)Sale (S): 2,774 @ $2.99 · Sale (S): 2,556 @ $3.16EDGAR
2025-02-054Tango Therapeutics, Inc. (TNGX)Grant/award (A): 27,363 @ $0 · Grant/award (A): 164,175 (derivative) @ $0EDGAR
2024-02-084Tango Therapeutics, Inc. (TNGX)Sale (S): 1,422 @ $12.56 · Sale (S): 1,354 @ $12.62EDGAR
2024-02-054Tango Therapeutics, Inc. (TNGX)Grant/award (A): 22,859 @ $0 · Grant/award (A): 137,156 (derivative) @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1890662 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →